TG Therapeutics Inc (TGTX) — Cash Flow Reinvestment Rate
Latest as of June 2025:
0.54x
TG Therapeutics Inc (TGTX) has a Cash Flow Reinvestment Rate of 0.54x as of June 2025, reinvesting $4.03 Million (capex $42.00K plus investments $-3.99 Million) from operating cash flow of $7.44 Million. Explore TG Therapeutics Inc (TGTX) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.54x
(Capex + Investments) / Operating CF
Total Reinvested
$4.03 Million
Capex + Investments
Operating Cash Flow
$7.44 Million
USD
Capital Expenditures
$42.00K
USD
Annual Cash Flow Reinvestment Rate for TG Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for TG Therapeutics Inc. For live market cap and broader valuation context, see TG Therapeutics Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow